NEU 0.08% $13.01 neuren pharmaceuticals limited

Ann: Change of Director's Interest Notice-NEU.AX, page-17

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 232 Posts.
    lightbulb Created with Sketch. 43
    Anyone else notice this pattern? 4/5 of the last 5 changes in Directors Interest since 2013:

    - 29-May-2013
    Change of Director's Interest Notice
    -  5-Jun-2013
    FDA Fast Track granted for NNZ2566 Rett program

    - 19-Sep-2013
    Change of Director's Interest Notice
    - 18-Oct-2013
    Neuren receives Fast Track designation for Fragile X
    -  30-Oct-2013
    Orphan drug designation from FDA for NNZ-2566 in Fragile X

    - 9-Oct-2014
    Change of Director's Interest Notice
    - 12-Nov-2014
    Neuren successful in Rett syndrome Phase 2 trial

    - 5-Feb-2015
    Change of Director's Interest Notice
    - 16-Feb-2015
    FDA grants Neuren Orphan Drug designation for Rett syndrome


    - 16-May-2016
    Change of Director's Interest Notice?????!!!!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.